About My Health Careers Internship MedBlogs Contact us
Cancer Cells Exhibit Cannibalism to Survive Chemotherapy: Here's How

Cancer Cells Exhibit Cannibalism to Survive Chemotherapy: Here’s How

Font : A-A+

  • Cancer cells exhibit the phenomenon of cannibalism
  • This provides them energy to survive chemotherapy
  • Surviving cancer cells can bring about tumor relapse
  • Inhibiting this cannibalistic behavior could lead to new treatments for cancer

Cancer cells are capable of surviving chemotherapy by 'eating' their neighboring tumor cells, reveals new research from the Tulane University School of Medicine in New Orleans, Louisiana, USA. The study indicates that this cannibalistic behavior of the cancer cells provide the energy to sustain themselves till the chemotherapy course is over, so that afterward they can cause tumor relapse.


Cancer Cells Exhibit Cannibalism to Survive Chemotherapy: Here’s How

The study, which has been published in the Journal of Cell Biology, was led by Dr. James Jackson, PhD, who is an Assistant Professor in the Department of Biochemistry and Molecular Biology at the Tulane University School of Medicine, New Orleans, Louisiana, USA.

Chemotherapy and Its Drawbacks

Chemotherapy is a treatment strategy for cancer that uses one or more specific anti-cancer drugs to kill the cancer cells so that they cannot spread to other sites in the body, which is technically termed as metastasis. The primary intention of chemotherapy is to cure the disease. However, it may also be administered for reducing the symptoms or prolonging life.

There are several classes of chemotherapy drugs, based on their mechanism of action. Some examples include the following: Chemotherapy drugs such as doxorubicin damage the DNA (deoxyribonucleic acid) of the cancer cells, thereby killing them. However, a small proportion of these cancer cells may survive the initial course of chemotherapy, which can give rise to relapsed tumors.

Tumor relapse is especially a problem in case of breast cancer, which retains a normal copy of the TP53 gene that encodes the tumor protein p53 (p53). The p53 protein is a tumor suppressor, which is responsible for regulating cell division by preventing cells from dividing and proliferating too fast or in an uncontrolled fashion.

The cancer cells that survive the onslaught of chemo drugs are responsible for causing a relapse. These surviving cancer cells generally stop proliferating and enter a dormant yet metabolically active state of suspended animation known as senescence. Interestingly, these senescent cancer cells produce copious amounts of inflammatory molecules and other factors that promote tumor reactivation. Therefore, chemotherapy-treated breast cancer patients having a normal copy of the TP53 gene are prone to relapse and have a poor survival rate.

"Understanding the properties of these senescent cancer cells that allow their survival after chemotherapy treatment is extremely important," says Dr. Crystal A. Tonnessen-Murray, a Postdoctoral Fellow in Jackson's laboratory at the Tulane University School of Medicine, USA.

Uniqueness of the Study

The study is unique due to the fact that it has made a ground-breaking discovery about the behavior of cancer cells, which was not known before. The research team found that breast cancer cells that survive chemotherapy and enter into a phase of senescence, frequently engulf adjacent cancer cells - a phenomenon akin to cannibalism.

The research team was surprised to find that this cannibalistic behavior was not only exhibited by cancer cells grown in cell culture in the laboratory, but also in tumors growing in mice. The research team also discovered that lung and bone cancer cells that had undergone senescence were also capable of engulfing their neighboring cancer cells.

It was further revealed that the senescent cancer cells activated a group of genes that are also found in white blood cells (WBC), which are responsible for engulfing pathogenic microbes or dead cellular debris. Subsequently, these materials are degraded in cellular organelles known as lysosomes, which have an acidic environment, thereby facilitating digestion. Likewise, the senescent cancer cells, after 'eating' their neighboring cancer cells, also digest the cellular debris within their lysosomes.

Implications of the Study

The phenomenon of cannibalism that is exhibited by cancer cells helps them to stay alive. Senescent cancer cells that engulfed a neighboring cancer cell survived significantly longer in cell culture, compared to those that didn't exhibit this cannibalistic behavior.

Engulfing neighboring cancer cells could provide the senescent cancer cells with the necessary energy resources for them to survive the attack of chemo drugs, as well as produce factors responsible for bringing about tumor relapse.

Concluding Remarks

Jackson concludes: "Inhibiting this process may provide new therapeutic opportunities because we know that it is the breast cancer patients with tumors that undergo TP53-mediated senescence in response to chemotherapy that have a poor response and poor survival rates."

Funding Source

The study was funded by the US Department of Defense, Virginia, the National Institutes of Health (NIH), and the NIH/National Institute of General Medical Sciences, Bethesda, Maryland, USA.

Reference :
  1. Chemotherapy-induced senescent cancer cells engulf other cells to enhance their survival - (http://jcb.rupress.org/content/early/2019/09/16/jcb.201904051)

Source: Medindia

News A-Z
News Category
What's New on Medindia
International Day of Persons with Disabilities 2021 - Fighting for Rights in the Post-COVID Era
Effect of Blood Group Type on COVID-19 Risk and Severity
Woman with Rare Spinal Cord Defect from Birth Sues Doctor
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Cancer and Homeopathy Parkinsons Disease Surgical Treatment Colorectal Cancer Cancer Facts Cancer Tattoos A Body Art Common Lifestyle Habits that Cause Diseases Health Benefits of Dandelion Plant Neck Cracking Immune Checkpoint Inhibitors for Cancer Treatment 

Recommended Reading
Chemotherapy Demand May Increase by 2040
Chemotherapy demand might rise to more than 50 percent by 2040, reveals a global study. Therefore, ....
New Blood Test Helps Predict Risk of Breast Cancer Recurrence
A simple and special blood test may help predict if a newly diagnosed breast cancer patient will ......
Combination of Anti-cancer Drug and Anti-rheumatic Drug Helps Kill Cancer Cells
The synergistic effect of anticancer and antirheumatic drug was found to kill cancer cells and ......
Delay in Chemotherapy after Breast Cancer Surgery may Reduce Survival
Breast cancer patients with delayed treatment are shown to have poor survival rates. The delay, a .....
Colorectal Cancer
Colorectal cancer is a cancer that starts in the colon or the rectum. Colorectal cancer is the third...
Common Lifestyle Habits that Cause Diseases
Cigarette smoking, unhealthy diets, overuse of alcohol, and physical inactivity are some of the most...
Health Benefits of Dandelion Plant
What is dandelion? Dandelion greens are nutrition powerhouses with a wide range of health benefits. ...
Immune Checkpoint Inhibitors for Cancer Treatment
Immune checkpoint inhibitors are promising drugs to treat a variety of cancers and the FDA has appro...
Neck Cracking
Neck cracking or neck popping is caused by quick movements to loosen the ligaments and joints of the...
Tattoos A Body Art
Tattoos are a rage among college students who sport it for the ‘cool dude’ or ‘cool babe’ look...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use